Table 3.

Primary and secondary clinical success, mortality, and cause of death.

	csAAS	TAI	Others	Total
Primary clinical success∗	45/48 (93.7%)	23/23 (100%)	2/3 (66.6%)	70/74 (94.5%)
Secondary clinical success∗	44/48 (91.6%)	23/23 (100%)	2/3 (66.6%)	69/74 (93.2%)
TEVAR related deaths∗	0	0	2 (2.6%)	2 (2.6%)
<30 days mortality	0	0	1 (1.3%)	1 (1.3%)
>30 days mortality	10 (13.5%)	0	1 (1.3%)	11 (14.8%)
Causes of death	10 (13.5%)	0	2 (2.6%)	12 (15.4%)
Multiorgan failure	0	0	2 (2.6%)	2 (2.6%)
Stroke	1 (1.3%)	0	0	1 (1.3%)
No TEVAR related deaths	9 (12.1%)	0	0	9 (12.1%)

# categorical data are presented as numbers (n) with percentage (%); ^∗ according to society of vascular surgery society [4].